期刊文献+

右美托咪定对扁桃腺切除术患儿七氟醚复合麻醉苏醒期噪动的影响 被引量:2

Efficacy of Dexmedetomidine on Emergence Agitation During the Recovery Period of Sevoflurane Anesthesia in Pediatric Undergoing Tonsillectomy
下载PDF
导出
摘要 目的研究右美托咪定对扁桃腺切除术患儿七氟醚复合麻醉苏醒期躁动的影响。方法选取2015年1月—2017年1月我院拟在全麻气管插管下行扁桃体及腺样体切除手术的患儿80例,将其随机分为观察组和对照组,每组各40例。观察组插入气管导管后,输注右美托咪定0.2μg/(kg·h),对照组则输注等剂量的生理盐水,比较两组麻醉苏醒期躁动的影响。结果观察组的PAED评分低于对照组,观察组的躁动发生率、不良反应发生率均低于对照组,观察组的PACU停留时间低于对照组,差异均有统计学意义(P<0.05)。结论使用右美托咪定有助于减少患儿苏醒期躁动,帮助患儿平稳度过麻醉苏醒期,并减少术后的不良反应。 Objective To study the effect of dexmedetomidine on emergence agitation during the recovery period of sevoflurane anesthesia in pediatric undergoing tonsillectomy. Methods 80 cases of tonsillectomy pediatric treated with sevoflurane anesthesia admitted in our hospital from January 2015 to January 2017 were divided into control group and observation group by method of random sampling, 40 cases in each group, the observation group was administered dexmedetomidine treatment 0.2 pg/(kg'h), and the control group was administered same dose of normal saline treatment, the efficacy of emergence agitation during recovery period of two groups were observed and compared. Results In observation group, the PAED score, emergence agitation rate, adverse reaction rate and PACU staying period were lower than these in control group, the difference was statistically significant (P〈0.05). Conclusion The use of dexmedetomidine can reduce emergence agitation in pediatric, and help pediatric get through the anesthesia recovery period, and reduce postoperative adverse reactions.
作者 韦泽立
出处 《中国继续医学教育》 2017年第11期91-93,共3页 China Continuing Medical Education
关键词 右美托咪定 扁桃腺切除术 患儿 七氟醚复合麻醉 dexmedetomidine tonsillectomy pediatric sevoflurane anesthesia
  • 相关文献

参考文献8

二级参考文献72

  • 1孙敏.右美托咪定用于小儿阑尾炎手术七氟醚麻醉后小儿苏醒期躁动的影响[J].医学信息(医学与计算机应用),2014,0(16):166-167. 被引量:4
  • 2Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med ,2002,30:119-141.
  • 3Ostermann ME, Keenan SP, Seiferling RA, et al. Sedation in the intensive care unit :a systematic review. JAMA, 2000,283: 1451-1459.
  • 4Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery:dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth,2003,17:576-584.
  • 5Triltsch AE, Welte M, yon Homeyer P, et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase Ⅱ study. Crit Care Med, 2002,30 : 1007- 1014.
  • 6Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care, 2000,4 : 302-308.
  • 7Arain SR, Ruehlow RM, Uhrich TD, et al. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg, 2004, 98: 153- 158.
  • 8Kamibayashi T, Maze M. Clinical uses of alpha2 adrenergic agonists. Anesthesiology, 2000,93 : 1345-1349.
  • 9Maze M,Scarfini C,Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin, 2001,17 : 881-897.
  • 10Ingersoll-Weng E, Manecke GR Jr, Thistlethwaite PA. Dexmedetomidine and cardiac arrest. Anesthesiology, 2004, 100:738-739.

共引文献223

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部